B_Sources Sought Notice.docx
DOCX document 23 KB Posted
- Attached to
- Toxicology Consultant Support Services Federal contract opportunity
- Solicitation number
- 75N95025Q00046
About this file
This document is a Sources Sought notice for Toxicology Consultant Support Services, Solicitation Number 75N95025Q00046, issued by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.
The notice seeks qualified small business sources with expertise in pharmaceutical toxicology or pharmacology to provide executive-level consulting services for the NIH Blueprint Neurotherapeutics Network and other NIH neuroscience drug discovery and development programs. Key requirements include a minimum of 15 years of regulatory drug development toxicology experience, expertise in small molecule and CNS drugs, and the ability to identify and address development challenges. Qualified respondents must demonstrate their capabilities in a capability statement submitted by December 3, 2024. This is not a request for proposals, and responses will not be considered adequate for any subsequent solicitation. The government reserves the right to use the information provided for any legally appropriate purpose.
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sources Sought notice # 75N95025Q00046
Title: Toxicology Consultant Support Services
This is a Small Business Sources Sought notice. THIS IS NOT A REQUEST FOR PROPOSALS, ABSTRACTS, OR QUOTATIONS. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement.
The purpose of this notice is to obtain information regarding:
1. The availability and capability of qualified small business sources.
2. Whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and
3. Their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition.
Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible.
The applicable NAICS code for this acquisition is 541690 - Other Scientific and Technical Consulting Services. An organization that is not considered a small business under this NAICS code should not submit a response to this notice.
PROJECT REQUIREMENTS
The National Institute of Neurological Disorders and Stroke (NINDS) is seeking executive (senior scientific)-level, industry-experienced drug discovery and development consultants with expertise in Toxicology to provide technical guidance to the following programs:
| • | Toxicology consulting support to the NIH Blueprint Neurotherapeutics Network [BPN] drug discovery and development programs. |
| • | Toxicology consulting support to the Help End Addiction Longterm [HEAL] drug discovery and development programs. |
| • | Other NIH neuroscience-focused drug discovery and development programs. |
The NIH Blueprint for Neuroscience Research, a consortium of 8 NIH Institutes and Centers that support neuroscience research, established the Blueprint Neurotherapeutics Network as a pipeline between the typical endpoint of NIH-funded research and the beginning of industry drug development. The BPN provides neuroscience researchers with funding and access to a full range of industry-style drug development services and expertise. The program is intended for projects requiring medicinal chemistry optimization and contract research organization (CRO) support through Phase I clinical testing. Each project is directed by a Lead Development Team (LDT) composed of the principal investigator (PI), industry consultants hired by NIH, and NIH staff. This team maps out a research strategy, including milestones, and oversees implementation by CROs. Bioactivity and efficacy studies are funded through an award to the PI; other research services can be provided without cost to the PI through NIH contracts.
The purpose of this requirement is to procure subject matter expert (SME) consultant services to provide technical recommendations and advice to the NIH Blueprint Neurotherapeutics Network.
The SMEs will provide Toxicology consulting services related to candidate small molecule and biologics therapeutics development. The NINDS anticipates that this acquisition will result in one (1) solicitation for an anticipated award of 1-2 Purchase Orders.
Toxicology consultants will be expected to provide executive (senior scientific)-level Toxicology expertise and contribute feedback and guidance on projects to the NIH and to LDT members. The role of the Toxicology consultant may include but is not limited to the following responsibilities and tasks:
| • | Consultants may be asked to help establish toxicology endpoints and milestones for a project, recommend assays to be incorporated into a testing funnel or development plan, design toxicology and pharmacology studies, and interpret data delivered by research service contractors. |
| • | In partnership with other consultants, contractors, and the NIH staff, advise, strategically plan, and manage programs to facilitate lead optimization, IND enabling, and clinical studies. |
| • | Serve as a resource to lead development team members for toxicology requirements, pharmacology and logistics to conduct drug development activities for small molecule compounds from the preclinical stage through to the initial clinical stage. |
| • | Serve as the toxicology expert in order to identify potential developmental challenges and suggest strategies to address these challenges. |
| • | Collaborate on design of investigative toxicology studies in support of development compounds. |
| • | Review toxicology sections of regulatory filings provided by CROs [Contract Research Organizations] or PIs [Principal Investigators] Collaborate on the design of investigative studies in support of development compounds. |
Education and work experience requirements
| • | An advanced degree in pharmaceutical toxicology or pharmacology related scientific discipline is required. PhD is preferred. |
| • | Current DABT Board certification preferred. |
| • | Small molecule and CNS experience preferred. |
| • | A minimum of 15 years regulatory drug development toxicology. |
| • | Biologics experience is a plus. |
| • | Must have experiences in identifying and anticipating problems early in a project, overcoming |
technical difficulties, and making strategic decisions that make wise use of limited resources (including terminating projects that appear unlikely to succeed).
Interested organizations must demonstrate and document, in any capability statements submitted, extensive experience with and the ability to perform the above tasks. Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. Documentation may include, but not be limited to, contracts both Government and commercial the organization performed, references, i.e., names, titles, telephone numbers and any other information serving to document the organizations capability, e.g., awards, commendations, etc.
All capability statements must provide the following: 1) company name, address and UEI number; 2) point of contact, 3) phone/email; 4) NAICS Codes; 5) business size and status; 6) capability information in response to the requirement and qualifications identified in this notice; and 7) type of small business your organization classifies itself as.
Electronic capability statements will be accepted by the primary point of contact at polina.klimenkova@nih.gov in the form of a single PDF file with the subject line: “Capability Statement 75N95025Q00046” NO LATER THAN December 3rd, 2024 at 12:00 PM EST.
THIS NOTICE IS NOT A REQUEST FOR PROPOSALS. This notice is for information and planning purposes only and does not obligate the Government to award a contract or otherwise pay for the information provided in this response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in SAM. However, responses to this notice will not be considered adequate responses to the subsequent solicitation.
File details come from the government source that posted it. Updated .